Diego Germini

Diego Germini has worked in a variety of roles in the biotechnology and health sciences fields. In 2021, they began working as a Project Leader for PEP-Therapy. In 2020, they were a Senior Scientist at OregonTherapeutics. From 2016 to 2018, they were an Invited Professor at the Saint-Petersburg Polytechnic University. From 2014 to 2016, they were a Postdoctoral Researcher at Gustave Roussy, where they studied molecular mechanisms of cancerogenesis, chromosomal translocations, and project management. From 2008 to 2014, they were a PhD Student/Post Doc at the Azienda Ospedaliero-Universitaria di Parma. In 2006, they completed an Internship for Master of Science in Health Biotechnology at the Università degli studi di Parma. In 2004, they completed an Internship for bachelor of Science in Biotechnology at the Università degli studi di Parma.

Diego Germini obtained a Bachelor's degree in Biotechnology from Università degli Studi di Parma in 2005, following a period of study from 2001-2005. Diego then went on to obtain a Master of Science - MS in Health Biotechnology from Università degli Studi di Parma between 2004-2007. Finally, they completed a Doctor of Philosophy - PhD in Virology and Microbiology from Università degli Studi di Parma between 2008-2012.